KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash from Financing Activities (2016 - 2025)

Eli Lilly's Cash from Financing Activities history spans 17 years, with the latest figure at -$2.9 billion for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 1176.63% year-over-year to -$2.9 billion; the TTM value through Dec 2025 reached -$2.2 billion, down 279.92%, while the annual FY2025 figure was -$2.2 billion, 279.92% down from the prior year.
  • Cash from Financing Activities reached -$2.9 billion in Q4 2025 per LLY's latest filing, down from $531.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $3.5 billion in Q4 2023 to a low of -$2.9 billion in Q4 2025.
  • Average Cash from Financing Activities over 5 years is -$351.2 million, with a median of -$387.2 million recorded in 2021.
  • The largest YoY upside for Cash from Financing Activities was 543.21% in 2025 against a maximum downside of 1176.63% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.5 billion in 2021, then grew by 25.23% to -$1.1 billion in 2022, then surged by 410.59% to $3.5 billion in 2023, then crashed by 106.36% to -$225.5 million in 2024, then plummeted by 1176.63% to -$2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Cash from Financing Activities are -$2.9 billion (Q4 2025), $531.0 million (Q3 2025), and -$1.2 billion (Q2 2025).